Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 538 of the 538 references it cites were found in a registry or an index.

Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance

Venkatakrishnan, Karthik, von Moltke, Lisa L., Greenblatt, David J. · 2000 · Clinical Pharmacokinetics

Abstract

This article reviews the metabolic pharmacokinetic drug-drug interactions with the systemic antifungal agents: the azoles ketoconazole, miconazole, itraconazole and fluconazole, the allylamine terbinafine and the sulfonamide sulfamethoxazole. The majority of these interactions are metabolic and are caused by inhibition of cytochrome P450 (CYP)-mediated hepatic and/or small intestinal metabolism of coadministered drugs. Human liver microsomal studies in vitro, clinical case reports and controlled pharmacokinetic interaction studies in patients or healthy volunteers are reviewed. A brief overview of the CYP system and the contrasting effects of the antifungal agents on the different human drug-metabolising CYP isoforms is followed by discussion of the role of P-glycoprotein in presystemic extraction and the modulation of its function by the antifungal agents. Methods used for in vitro drug interaction studies and in vitro-in vivo scaling are then discussed, with specific emphasis on the azole antifungals. Ketoconazole and itraconazole are potent inhibitors of the major drug-metabolising CYP isoform in humans, CYP3A4. Coadministration of these drugs with CYP3A substrates such as cyclosporin, tacrolimus, alprazolam, triazolam, midazolam, nifedipine, felodipine, simvastatin, lovastatin, vincristine, terfenadine or astemizole can result in clinically significant drug interactions, some of which can be life-threatening. The interactions of ketoconazole with cyclosporin and tacrolimu…

Overview

Integrity signals

Registry

Crossref · 10.2165/00003088-200038020-00002

Cites

538 of 538 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 537 references

Research works printed but not linked: 131

  1. Hajek, 1982, J Pharmacol Exp Ther, 223, 97
  2. Shimada, 1994, J Pharmacol Exp Ther, 270, 414
  3. Hargreaves, 1994, Br J Clin Pharmacol, 38, 175P
  4. Lampen, 1995, Drug Metab Dispos, 23, 1315
  5. Gentile, 1996, J Pharmacol Exp Ther, 277, 105
  6. Pichard, 1990, Drug Metab Dispos, 18, 595
  7. Lavrijsen, 1993, Allergy, 48, 34
  8. Zhou-Pan, 1993, Cancer Res, 53, 5121
  9. von Moltke, 1994, J Pharmacol Exp Ther, 268, 1278
  10. von Moltke, 1996, J Pharmacol Exp Ther, 276, 370
  11. Jurima-Romet, 1994, Drug Metab Dispos, 22, 849
  12. Nakasa, 1993, Mol Pharmacol, 44, 216
  13. Bourrie, 1996, J Pharmacol Exp Ther, 277, 321
  14. Kunze, 1996, Drug Metab Dispos, 24, 414
  15. Fitzsimmons, 1997, Drug Metab Dispos, 25, 256
  16. Code, 1997, Drug Metab Dispos, 25, 985
  17. Erickson, 1997, ISSX Proc, 12, 49
  18. Heyn, 1996, Drug Metab Dispos, 24, 948
  19. Ko, 1998, Drug Metab Dispos, 26, 775
  20. Chang, 1993, Cancer Res, 53, 5629
  21. Hall, 1987, J Pharmacol Exp Ther, 240, 216
  22. Wienkers, 1996, Drug Metab Dispos, 24, 610
  23. Leeder, 1998, Clin Pharmacol Ther, 63, 216
  24. Newton, 1995, Drug Metab Dispos, 23, 154
  25. von Moltke, 1998, Pharm Pharmacol Commun, 4, 443
  26. Schuetz, 1996, Mol Pharmacol, 49, 311
  27. Schinkel, 1998, Int J Clin Pharmacol Ther, 36, 9
  28. Schmider, 1995, J Pharmacol Exp Ther, 275, 592
  29. Obach, 1996, Drug Metab Dispos, 24, 1047
  30. Obach, 1997, Drug Metab Dispos, 25, 1359
  31. Black, 1996, Drug Metab Dispos, 24, 422
  32. Ring, 1995, J Pharmacol Exp Ther, 275, 1131
  33. Kunze, 1996, Drug Metab Dispos, 24, 429
  34. Ervine, 1996, Drug Metab Dispos, 24, 211
  35. Olkkola, 1996, Anesth Analg, 82, 511
  36. Negroni, 1993, Arch Med Res, 24, 387
  37. Gomez, 1994, Clin Pharmacol Ther, 55, 209
  38. Albengres, 1992, Int J Clin Pharmacol Ther Toxicol, 30, 555
  39. Canafax, 1991, Transplant Proc, 23, 1041
  40. Butman, 1991, J Heart Lung Transplant, 10, 351
  41. First, 1993, Transplant Proc, 25, 591
  42. Sorenson, 1994, Transplant Proc, 26, 2822
  43. Odocha, 1996, Transplant Proc, 28, 907
  44. Schroeder, 1987, J Heart Transplant, 6, 84
  45. Karlix, 1993, Transplantation, 56, 1554
  46. Pichard, 1990, Drug Metab Dispos, 18, 711
  47. Horton, 1992, J Heart Lung Transplant, 11, 1127
  48. Lo, 1997, Br J Clin Pharmacol, 43, 340
  49. Karanam, 1994, Drug Metab Dispos, 22, 811
  50. Sattler, 1992, Drug Metab Dispos, 20, 753
  51. Iwasaki, 1993, Res Commun Chem Pathol Pharmacol, 82, 209
  52. Assan, 1994, Diabete Metab, 20, 49
  53. Vanakoski, 1995, Int J Clin Pharmacol Ther, 33, 518
  54. Kronbach, 1989, Mol Pharmacol, 36, 89
  55. Pichard, 1995, Drug Metab Dispos, 23, 1253
  56. Koyama, 1997, J Pharmacol Exp Ther, 281, 1199
  57. Nielsen, 1996, J Pharmacol Exp Ther, 277, 1659
  58. Rotzinger, 1998, Drug Metab Dispos, 26, 572
  59. Pirmohamed, 1995, J Pharmacol Exp Ther, 272, 984
  60. Linnet, 1997, Drug Metab Dispos, 25, 1379
  61. Bajpai, 1996, Drug Metab Dispos, 24, 1401
  62. Molholm Hansen, 1975, BMJ, 2, 684
  63. Yun, 1993, Drug Metab Dispos, 21, 403
  64. Ling, 1995, Drug Metab Dispos, 23, 631
  65. Rodrigues, 1995, Drug Metab Dispos, 23, 765
  66. Kuang, 1994, Clin Pharmacol Ther, 55, 139
  67. Kuang, 1995, Clin Pharmacol Ther, 57, 185
  68. Kuang, 1995, Clin Pharmacol Ther, 57, 185
  69. Paserchia, 1994, Clin Pharmacol Ther, 55, 146
  70. Eller, 1991, Clin Pharmacol Ther, 49, 130
  71. Cantilena, 1995, Clin Pharmacol Ther, 57, 185
  72. Tsai, 1997, J Formosan Med Assoc, 96, 144
  73. Van Peer, 1993, Allergy, 48, 34
  74. Brannan, 1995, Clin Pharmacol Ther, 57, 193
  75. Linthoudt, 1996, J Heart Lung Transplant, 15, 1165
  76. Ludwig, 1989, Drug Intell Clin Pharm, 23, 858
  77. Jonsson, 1995, Drug Metab Dispos, 23, 137
  78. Guengerich, 1988, Mol Pharmacol, 33, 500
  79. Pillans, 1993, NZ Med J, 106, 436
  80. Meyboom, 1997, NZ Med J, 110, 300
  81. Kovacs, 1986, Ther Hung, 34, 167
  82. Swinney, 1990, Drug Metab Dispos, 18, 859
  83. Seaton, 1990, Drug Intell Clin Pharm, 24, 1177
  84. Pillans, 1996, NZ Med J, 109, 346
  85. Kazmier, 1976, Mayo Clin Proc, 51, 782
  86. Errick, 1978, Am J Hosp Pharm, 35, 1399
  87. Greenlaw, 1979, Am J Hosp Pharm, 36, 1155
  88. Cook, 1994, J Fam Pract, 39, 589
  89. Sharer, 1996, Drug Metab Dispos, 24, 487
  90. Blyden, 1986, Int J Clin Pharmacol Ther Toxicol, 24, 225
  91. Purba, 1986, Br J Clin Pharmacol, 21, 603P
  92. Brockmeyer, 1997, Eur J Med Res, 2, 377
  93. Tjia, 1996, J Pharmacol Exp Ther, 276, 912
  94. Murphy, 1987, Ir Med J, 80, 123
  95. Nix, 1992, Clin Pharmacol Ther, 51, 183
  96. Reitberg, 1983, Clin Pharm, 2, 441
  97. Kovacs, 1999, Clin Pharmacol Ther, 65, 132
  98. Kroemer, 1992, J Pharmacol Exp Ther, 260, 1052
  99. Fabre, 1993, Drug Metab Dispos, 21, 978
  100. Guengerich, 1986, Mol Pharmacol, 30, 287
  101. Funck-Brentano, 1989, J Pharmacol Exp Ther, 249, 134
  102. McNulty, 1989, Clin Pharm, 8, 222
  103. Abolfathi, 1995, Clin Pharmacol Ther, 57, 215
  104. Cone, 1996, West J Med, 165, 322
  105. Prueksaritanont, 1997, Drug Metab Dispos, 25, 1191
  106. Stearns, 1995, Drug Metab Dispos, 23, 207
  107. Otton, 1988, J Pharmacol Exp Ther, 247, 242
  108. Masubuchi, 1994, Drug Metab Dispos, 22, 909
  109. Oldham, 1997, Drug Metab Dispos, 25, 970
  110. Cribb, 1995, Drug Metab Dispos, 23, 406
  111. Zhao, 1996, J Pharmacol Exp Ther, 279, 1327
  112. Zhao, 1997, Drug Metab Dispos, 26, 188
  113. Muindi, 1993, Cancer Res, 53, 1226
  114. Buggia, 1996, Anticancer Res, 16, 2083
  115. Rahman, 1994, Cancer Res, 54, 5543
  116. Cresteil, 1994, Cancer Res, 54, 386
  117. Haaz, 1998, Cancer Res, 58, 468
  118. Rajaonarison, 1992, Drug Metab Dispos, 20, 578
  119. Kumar, 1996, J Pharmacol Exp Ther, 277, 423
  120. Koudriakova, 1998, Drug Metab Dispos, 26, 552
  121. Chiba, 1996, Drug Metab Dispos, 24, 307
  122. Kerr, 1997, Clin Pharmacol Ther, 61, 147
  123. Cato, 1997, Drug Metab Dispos, 25, 1104
  124. Jordan, 1998, J Natl Med Assoc, 90, 622
  125. Tateishi, 1996, Anesth Analg, 82, 162
  126. Feierman, 1996, Drug Metab Dispos, 24, 932
  127. Labroo, 1995, Drug Metab Dispos, 23, 490
  128. Ekstrom, 1996, Drug Metab Dispos, 24, 955
  129. Antila, 1998, Int J Clin Pharmacol Ther, 36, 446
  130. Wienkers, 1996, J Pharmacol Exp Ther, 277, 982
  131. Fleishaker, 1996, J Pharmacol Exp Ther, 277, 991

Cited by

See all 545

Metadata

Authors
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J.
Affiliations
Tufts University (US)
Corresponding author
Greenblatt, David J.
Venue
Clinical Pharmacokinetics
Published
2000-02
Volume
38
Issue
2
Pages
111-180
ISSN
0312-5963 (ISSN-L)
OpenAlex
W2076565275
Cited by
508
References
537
Citations by year
2026: 6 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 10 · 2021: 10 · 2020: 17 · 2019: 8 · 2018: 11 · 2017: 7 · 2016: 17 · 2015: 15 · 2014: 14 · 2013: 15 · 2012: 19
FWCI
3.64
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacokinetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (MH 34223, T32MH019924, MH-19924)
  • National Institute on Drug Abuse (DA05258)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
antifungal agents, drug-drug interactions, drug metabolism, cytochrome P450 inhibition, CYP3A4, CYP2C9, CYP2C19, P-glycoprotein, ketoconazole, fluconazole, itraconazole, miconazole, terbinafine, sulfamethoxazole, cyclosporine, tacrolimus, phenytoin, warfarin, immunosuppression
MeSH terms
Animals, Antifungal Agents, Cytochrome P-450 Enzyme System, Drug Interactions, Pharmaceutical Preparations, Humans, Oxidation-Reduction, ATP Binding Cassette Transporter, Subfamily B, Member 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance. https://app.cochat.ai/papers/10.2165/00003088-200038020-00002
The paper
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2000). Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200038020-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.